Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention.
The near-term outlook for the Zacks Paper and Related Products industry is uncertain. Stocks like KLBAY and SEOAY are braving the industry headwinds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results